Diabetes care research
New research in Diabetes care
Pediatric Afrezza Study
"TI use was safe over 26 weeks without affecting pulmonary function and was associated with greater treatment satisfaction and less weight gain compared with RAA, supporting TI as a treatment option for some pediatric patients with type 1 diabetes."
Scientists at the UFDI conducted a new study in Diabetes Care, testing a form of insulin that can be inhaled by children and teens with type 1 diabetes who seek an alternative to mealtime injections. In addition to causing less weight gain compared to standard injected insulin, the inhaled insulin proved to be safe and effective, with high treatment satisfaction among families.
Department:
MD-PEDS-ENDOCRINOLOGY
Michael J Haller M.D.
Professor and Chief
Phone:
(352) 273-9264
Email:
hallerms@ufl.edu